On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
disease modification
.
Show all posts
Showing posts with label
disease modification
.
Show all posts
Friday, December 15, 2023
Randomized start design (RSD), delayed start design, randomized withdrawal design to assess disease modification effect
›
In the latest Global CardioVascular Clinical Trialists (CVCT) Workshop ", one of the topics was "How to assess the disease modific...
Thursday, December 14, 2023
Defining 'disease modification effect', 'disease modification therapy (DMT)' or 'disease modifier'
›
The concept of "disease modification," "disease modification therapy (DMT)," and "disease modifier" has been a...
›
Home
View web version
